L6 ALS Flashcards

1
Q

ALS definition

A

progressive neurodegenerative disease that affects upper and lower motor neurons

eventually leads to paralysis and death

no cure for ALS, can be medically managed to reduce S/S and prolong life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Mean survival time

A

2-5 years on average

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Epidemiology ALS

A

90-95% of cases are sporadic

prevalence of disease is 5.2 per 100,000

most people are between 40 to 70, average of 55

more common in men than women, caucasian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pathophysiology of ALS

A

onset of this disease is sporadic and cause is unknown

motor neurons are uniquely vulnerable to the disease process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pattern of loss for motor neurons

A

loss of UMNs in CST and motor cortex

loss of LMNs in brainstem and anterior horn of SC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pathophysiology of ALS

A

factors that contribute to motor neuron cell degeneration and/or death

-oxidative stress
-defective glutamate metabolism
-genetic variations
-cytoskeletal protein defects preventing normal cell
-autoimmune dysfunction
-inflammatory responses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Limb-onset ALS

A

extremity and bulbar tract signs

most common, 2/3rds of patients

often starts in the limbs and then progresses to proximal tracts controlling swallowing and respiration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bulbar ALS

A

1/3 of patients

starts with difficulty with speech and trouble swallowing that can be followed by limb involvement in later stages

progresses more quickly than limb onset variant, shortening survival time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ALS-plus syndrome

A

extremity and bulbar symptoms and dementia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Medical Diagnosis of ALS

A

diagnosis of exclusion, delayed diagnosis and treatment

average time to diagnosis to 10-15 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Arlie House Criteria

A

presence of LMN and UMN symptoms in the bulbar region and at least 2 spinal regions

presence of LMN and UMN symptoms in 3 spinal regions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Other characteristics suggestive of ALS

A

absence of sensory symptoms

progressive spread of symptoms or signs

no evidence of other disease processes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnoses that are against ALS

A

presence of isolated radicular pain

symmetric proximal OR distal limb weaknesses

cog wheel rigidity

prominent sensory loss

isolated fasciculations or cramps without weakness

rapid onset with no progression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

UMN Lesion Characteristics

A

Weakness
Increased Reflexes
Increased Muscle Tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

LMN Lesion characteristics

A

Weakness
atrophy
fasciculations
decreased reflexes
decreased muscle tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Features of ALS associated with poor prognosis

A

-elderly onset
-elderly females presenting with bulbar-onset
-pts whose ALS diagnosis has been given less than 8 mo after symptom onset
-patients losing more than 1.4 points/mo

17
Q

Medical Treatment ALS

A

predominately symptom management

slow down the progression of disease

18
Q

Predominately symptom management

A

-respiratory
-dysphagia
-sialorrhea = excesive salivation
-pseudobulbar affect = episodes of uncontrollable laughter or crying
-communication
-muscle spasms and pain
-weakness and loss of functional mobility
-depression

19
Q

Slowing the progression of the disease

A

riluzole

thought to reduce glutamate-induced excitotoxicity

improved survival

20
Q

Patient and family education

A

-disease progression, will lead to death
-no cure
-medications can lessen symptoms
-therapy and AT can help improve QOL
-discussion of palliative progressing

21
Q

Speech Language Pathology

A

early in the disease process

see SLP to establish a baseline of speech rate

begin message and voice banking so that your own voice can be used in a speech generating device

22
Q

Alternative tech

A

thick barreled pen to improve grip strength

increasing cursor speed of a mouse so less movement is required

switch to single click on tech rather than double click

head, foot, eye movement controls

23
Q

ALS Functional Rating Scale Revised

A

measure of physical function for patients with ALS created in 1991

12 question scale with likert scale responses

total score range 0-48, with lower score is more impaired

stronger predictor of survival than muscle strength or respiratory function

24
Q

Areas that are measured in ALS functional rating scale

A

Bulbar = speech, salivation, swallowing

fine motor = handwriting, cutting food, dressing and hygiene

gross motor = turning in bed, walking, climbing stairs

respiratory = dyspnea, orthopnea, respiratory insufficiency

25
Q

Palliative Care

A

meant to improve the quality of life of patients who have a serious or life-threatening disease. approach to care that addresses the person as a whole, not just their disease. Goal is to prevent or treat as early as possible, the symptoms and side effects of the disease and its treatment in addition to any related psychosocial and spiritual problems. Anyone can receive palliative care regardless of their age or stage of disease

26
Q

Overall goal of care for ALS

A

slow the decline of loss of function and provide more support as they decline

27
Q

Short term effects of exercise in ALS

A

Improved ALSFRS-R = possibly hypertrophy, more likely due to increased recruitment by collateral innervation

No improvement in ALSFRS-R = early in the disease it is difficult to maintain high score levels of b/c of natural history, possible that these patients were under-dosed

28
Q

Clinical Bottom Line of short term effects of exercise

A

you need to use outcome measures to monitor your patient’s response to a new exercise program and adjust plan of care accordingly

29
Q

Medium Term Effects of Exercise in ALS

A

4/5 studies showed less loss of function for those that did aerobic exercise

one study showed an exception; they did both strength and aerobic exercise

30
Q

Clinical Bottom Line of Medium Term Effects of Exercise in ALS

A

Training must be balanced between muscle overwork and underwork. overwork may increase fatigue and weakness

five times/week would not be recommended for ALS patients

not enough research for intensity/frequency

31
Q

Long-Term Effects of Exercise in ALS

A

5/6 studies showed less loss of function in exercise group

there is a consistent documented benefit of exercise on function in patients with ALS

even small changes can improve QOL

32
Q

Overall Clinic Bottom Line for exercise

A

combining strength training and aerobic exercise at moderate intensity, 2/week

optimize functional benefit without increasing fatigue

must monitor for overwork fatigue

33
Q

Rehab in Reverse

A

as the disease progresses so will your interventions and goals

go from least restrictive to more supportive equipment

education from how to be independent to caregiver support

exercise to increase strength to then maintain strength for as long as possible

34
Q

Late stage ALS

A

most individuals wished they had begun sooner with wheelchair